Healthy Subjects

A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis

Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.

Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients

Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission

Physiologic Monitoring of Antidepressant Treatment Response

Study Evaluating Venlafaxine ER in Recurrent Depression

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease

Tedizolid Phosphate (TR-701 FA, MK-1986) vs Linezolid for the Treatment of Nosocomial Pneumonia (MK-1986-002)

Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis

Lutein Absorption in Healthy Adults

A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Study Evaluating Venlafaxine ER in Patients With Panic Disorder

Study Evaluating Venlafaxine ER in Adults With Panic Disorder

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis

Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis

Efficacy, Safety and Local Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers